Sunday, May 15, 2016
9 - 11 a.m. |
| A6 |
Joint ATS/ERS/JRS Symposium on Severe Asthma: A Global Perspective |
| A7 |
ATS Mythbuster: Reversing Fibrosis in the Lungs Is Biological Mission (Im)possible |
| A8 |
Everything You Ever Wanted to Know About Sex Steroids and Lung Disease |
| A9 |
Controversies in Sleep Medicine: Davids, Goliaths, and Some Blood on the Floor! |
| A10 |
New Insights into the Pathogenesis and Treatment of Bronchopulmonary Dysplasia |
| A11 |
Global Lung Cancer Health Issues |
| A12 |
Entrepreneurship: Embracing the Innovative Environment - From Bench to Boardroom to Bedside |
| 2:15 - 4:15 p.m. |
| A82 |
Treatment of Early Stage and Screen-Detected Lung Cancer: A Pro/Con Debate |
| A86 |
Bringing Order to the Chaos of ACOS (Asthma-COPD Overlap Syndrome) |
| A87 |
E-Cigarette Vaping: Preclinical and Clinical Pulmonary Health Effects |
| A88 |
Community Acquired Pneumonia in the Elderly Patient |
| A89 |
From Beauty to Breaking Bad: Uncovering the World of Drug Induced Pulmonary Hypertension |
| A90 |
Abnormal Metabolism: Emerging Concepts in Understanding Lung Disease |
| A91 |
Hot Topics in Disparities in Pulmonary, Critical Care and Sleep Medicine |
Monday, May 16, 2016
9 - 11 a.m. |
| B6 |
Building E-Bridges: Tools at Our Fingertips for Enhancing Collaborative Care |
| B7 |
One Step at a Time: Has Physical Activity Delivered as an Outcome in Clinical Trials? |
| B8 |
Sleep, Sleep Disorders and Performance in Athletes |
| B9 |
Sickle Cell Disease and the Lung Across the Lifespan |
| B10 |
New Concepts in Asthma Biology |
| B11 |
Scientific Breakthroughs in Sarcoidosis Research and Phenotyping: The NHLBI GRADS Consortium |
| B12 |
Global Health: The What, Where and Why in the 21St Century |
| B13 |
Applied Physiology Is Alive and Well (President's Symposium) |
| 2:15 - 4:15 p.m. |
| B86 |
Immunotherapy for Lung Cancer: Power to the Host |
| B87 |
Beyond BMPR2: Emerging Roles of DNA Damage and Somatic Mutation in Pulmonary Arterial Hypertension |
| B88 |
Improving Real World Care Through Innovative Trial Designs |
| B89 |
Health Effects of Inhaled Toxins: From the Bench to the Trenches: A Global Perspective |
| B90 |
New Insights into the Predisposition, Pathogenesis, and Management of Fungal Pneumonia |
| B91 |
AJRCCM: Leading Journal in Respiratory, Critical Care and Sleep Medicine. Key Papers, Publication Ethics, New Initiatives |
Tuesday, May 17, 2016
9 - 11 a.m. |
| C5 |
The Brain After Critical Illness: Populations, Patients, and Pathways |
| C6 |
A Report Card on Education During Pulmonary Rehabilitation: How Are We Doing? |
| C7 |
Understanding Clinical Trials Data in Pulmonary Arterial Hypertension and Using Those Data in Practice |
| C8 |
Breaching Barriers: Targeted Delivery of Therapeutics to the Lung |
| C9 |
The Link Between Ciliary Assembly Defects, Neonatal Respiratory Distress and Bronchiectasis in Adulthood: A Primer on Primary Ciliary Dyskinesia |
| C10 |
Achieving "Environmental Justice": A Major Step Toward Respiratory Health Equality |
| C11 |
Pathogenesis and Treatment of Obstructive Lung Diseases: New Insights |
| C12 |
Biomarkers: Guideposts in the Roadmap to Improved Personalized and Precision Medicine |
| C13 |
Progress in Stem Cell Biology and Disease Applications |
| 2:15 - 4:15 p.m. |
| C86 |
Self-Management and Risk Reduction Challenges in Vulnerable Populations |
| C87 |
New Insights into the Genetic Basis of Pediatric Lung Disease |
| C88 |
Viral Community-Acquired Pneumonia |
| C89 |
Emerging Immune Functions of the Pulmonary Epithelium in Infection, Asthma, and Chronic Lung Disease |
| C90 |
It Takes Two to Tango: Right and Left Ventricle Interactions in Pulmonary Vascular Disease |
| C91 |
Optimizing ICU Rounds: Evidence-Based Approaches for Improving Patient Care and Teaching |
| C92 |
ATS Clinical Practice Guidelines: Clinical Practice on the Cutting Edge |
Wednesday, May 18, 2016
9 - 11 a.m. |
| D5 |
Improving Our Understanding of Respiratory Symptoms, Refractory Chronic Cough and Interprofessional Management |
| D6 |
Cannabis, Cannabimimetics, and Opiates in Sleep and Breathing |
| D7 |
Exploiting GPCRs for New and Improved Asthma Medicine |
| D8 |
ATS Mythbusters: Aberrant Tissue Regeneration Is a Primary Driver of COPD Pathogenesis |
| D9 |
Cracking the Cell Code: Understanding the Contribution of Cells to Pulmonary Vascular Diseases |
| D10 |
New Concepts in TB Immunity and Targets for Treatment |
| D11 |
ARDs and Inflammatory Injury |
| D12 |
Advances in Tobacco Dependence Treatment for the Hospitalized Patient |
| 1:30 - 3:30 p.m. |
| D85 |
Early Life Origins of Chronic Disease |
| D86 |
Controversies and Advances in the Management of Ventilator Associated Pneumonia |
| D87 |
Climate Changes and Respiratory Infections |
| D88 |
The Patient-Centered Juggernaut: The Right Move for Clinical Care, Policy, and Research? |
| D89 |
Novel Approaches to Treat Pulmonary Infections |
| D90 |
Respiratory Health in Migrant Populations |
